Log In
BCIQ
Print this Print this
 

ozarelix

Also known as: D-63153, SPI-153

  Manage Alerts
Collapse Summary General Information
Company Aeterna Zentaris Inc.
DescriptionFourth-generation luteinizing hormone-releasing hormone (LHRH) antagonist
Molecular Target Luteinizing hormone-releasing hormone (LHRH)
Mechanism of ActionLuteinizing hormone-releasing hormone (LHRH) receptor antagonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat hormone-dependent prostate cancer; Treat prostate cancer
Regulatory Designation
PartnerSpectrum Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today